Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: Case series and literature review

Lupus

Volumn 25, Issue 14, 2016, Pages 1509-1519

  Alves, S Custódio ^a   Fasano, S ^b   Isenberg, D A ^c  

^a Cascais Hospital   (Portugal)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

acute pancreatitis; autoimmune hepatic disease; Crohn's disease; gastrointestinal involvement; lupus enteritis; Systemic lupus erythematosus; ulcerative colitis

Indexed keywords

ACUTE PANCREATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CASE STUDY; CELIAC DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; ENTERITIS; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; COMPLICATION; DIGESTIVE SYSTEM DISEASES; ENGLAND; HEPATITIS, AUTOIMMUNE; INFLAMMATORY BOWEL DISEASES; LIVER CIRRHOSIS, BILIARY; PANCREATITIS; UNIVERSITY HOSPITAL;

CELIAC DISEASE; DIGESTIVE SYSTEM DISEASES; ENTERITIS; HEPATITIS, AUTOIMMUNE; HOSPITALS, UNIVERSITY; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER CIRRHOSIS, BILIARY; LONDON; LUPUS ERYTHEMATOSUS, SYSTEMIC; PANCREATITIS;

EID: 84994102187     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316655210     Document Type: Review

References (109)

1. Tian X-P, Zhang X,. Gastrointestinal involvement in systemic lupus erythematosus: Insight into pathogenesis, diagnosis and treatment. World J Gastroenterol 2010; 16: 2971-2977.
2. Ebert EC, Hagspiel KD,. Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol 2011; 45: 436-441.
3. Katsanos KH, Voulgari PV, Tsianos EV,. Inflammatory bowel disease and lupus: A systematic review of the literature. J Crohns Colitis 2012; 6): 735-742.
4. Hallegua DS, Wallace DJ,. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol 2000; 12: 379-385.
5. Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatol Oxf Engl 2005; 44: 902-906.
6. Pisetsky DS,. The role of innate immunity in the induction of autoimmunity. Autoimmun Rev 2008; 8: 69-72.
7. Shapeero LG, Myers A, Oberkircher PE, Miller WT,. Acute reversible lupus vasculitis of the gastrointestinal tract. Radiology 1974; 112: 569-574.
8. Zizic TM, Classen JN, Stevens MB,. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med 1982; 73: 525-531.
9. Medina F, Ayala A, Jara LJ, Becerra M, Miranda JM, Fraga A,. Acute abdomen in systemic lupus erythematosus: The importance of early laparotomy. Am J Med 1997; 103: 100-105.
10. Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D,. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6: 235-242.
11. Sultan SM, Ioannou Y, Isenberg DA,. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatol Oxf Engl 1999; 38: 917-932.
12. Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-547.
13. Lee C-K, Ahn MS, Lee EY, et al. Acute abdominal pain in systemic lupus erythematosus: Focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis 2002; 61: 547-550.
14. Kwok S-K, Seo S-H, Ju JH, et al. Lupus enteritis: Clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus 2007; 16: 803-809.
15. Sánchez-Guerrero J, Reyes E, Alarcón-Segovia D,. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992; 19: 623-625.
16. Janssens P, Arnaud L, Galicier L, et al. Lupus enteritis: From clinical findings to therapeutic management. Orphanet J Rare Dis 2013; 8: 67-67.
17. Ju JH, Min J-K, Jung C-K, et al. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol 2009; 5: 273-281.
18. Buck AC, Serebro LH, Quinet RJ,. Subacute abdominal pain requiring hospitalization in a systemic lupus erythematosus patient: A retrospective analysis and review of the literature. Lupus 2001; 10: 491-495.
19. Byun JY, Ha HK, Yu SY, et al. CT features of systemic lupus erythematosus in patients with acute abdominal pain: Emphasis on ischemic bowel disease. Radiology 1999; 211: 203-209.
20. Taourel P, Pradel J, Fabre JM, Cover S, Senéterre E, Bruel JM,. Role of CT in the acute nontraumatic abdomen. Semin Ultrasound CT MR 1995; 16: 151-164.
21. Cabrera GE, Scopelitis E, Cuellar ML, Silveira LH, Mena H, Espinoza LR,. Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin Rheumatol 1994; 13: 312-316.
22. Grimbacher B, Huber M, von Kempis J, et al. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: A clinical case report and review of the literature. Br J Rheumatol 1998; 37: 1023-1028.
23. Laing TJ,. Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: Successful treatment with pulse intravenous cyclophosphamide. Am J Med 1988; 85: 555-558.
24. Waite L, Morrison E,. Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy). Lupus 2007; 16: 841-842.
25. Medeiros DA, Isenberg DA,. Systemic lupus erythematosus and ulcerative colitis. Lupus 2009; 18: 762-763.
26. Chebli JM, Gaburri PD, de Souza AF, et al. Fatal evolution of systemic lupus erythematosus associated with Crohn's disease. Arq Gastroenterol 2000; 37: 224-226.
27. Fernández Rodríguez AM, Macías Fernández I, Navas García N,. Systemic lupus erythematosus and Crohn's disease: A case report. Reumatol Clin 2012; 8: 141-142.
28. Yamashita H, Ueda Y, Kawaguchi H, et al. Systemic lupus erythematosus complicated by Crohn's disease: A case report and literature review. BMC Gastroenterol 2012; 12: 174-174.
29. Katsanos KH, Voulgari PV, Goussia A, et al. Coexistence of Crohn's disease in a patient with systemic lupus erythematosus. Rheumatol Int 2013; 33: 2145-2148.
30. Michalopoulos G, Vrakas S, Makris K, Tzathas C,. Systemic lupus erythematosus in Crohn's disease: Drug-induced or idiopathic? Ann Gastroenterol Q Publ Hell Soc Gastroenterol 2015; 28: 408-409.
31. Dubois EL, Tuffanelli DL,. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964; 190: 104-111.
32. Zizic TM, Gastrointestinal manifestations. In: Schur P, (ed). The clinical management of systemic lupus erythematosus, New York: Grune & Stratton, 1983, pp. 153-166.
33. De Jager PL, Graham R, Farwell L, et al. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus. Genes Immun 2006; 7: 327-334.
34. Ferreiros-Vidal I, Garcia-Meijide J, Carreira P, et al. The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus. Rheumatol Oxf Engl 2003; 42: 570-574.
35. Chong WP, Ip WK, Lau CS, Chan TM, Padyukov L, Lau YL,. Common NOD2 polymorphisms in Hong Kong Chinese patients with systemic lupus erythematosus. Rheumatol Oxf Engl 2004; 43: 104-105.
36. Nitzan O, Elias M, Saliba WR,. Systemic lupus erythematosus and inflammatory bowel disease. Eur J Intern Med 2006; 17: 313-318.
37. Crişcov GI, Stana AB, Ioniue IK, Alexoae MM, Moraru E,. Coexistence of celiac disease and systemic lupus erythematosus in a 6-year-old girl-case report. Rev Medico-Chir Soc Medici Şi Nat Din Iaşi 2015; 119: 87-91.
38. Freeman HJ,. Adult celiac disease followed by onset of systemic lupus erythematosus. J Clin Gastroenterol 2008; 42: 252-255.
39. Gupta D, Mirza N,. Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: A rare association. Rheumatol Int 2008; 28: 1179-1180.
40. Marai I, Shoenfeld Y, Bizzaro N, et al. IgA and IgG tissue transglutaminase antibodies in systemic lupus erythematosus. Lupus 2004; 13: 241-244.
41. Rensch MJ, Szyjkowski R, Shaffer RT, et al. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus. Am J Gastroenterol 2001; 96: 1113-1115.
42. Denham JM, Hill ID,. Celiac disease and autoimmunity: Review and controversies. Curr Allergy Asthma Rep 2013; 13: 347-353.
43. Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF,. Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol 2012; 39: 1964-1970.
44. Picceli VF, Skare TL, Nisihara R, Kotze L, Messias-Reason I, Utiyama SRR,. Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients. Lupus 2013; 22: 1150-1155.
45. Rustgi AK, Peppercorn MA,. Gluten-sensitive enteropathy and systemic lupus erythematosus. Arch Intern Med 1988; 148: 1583-1584.
46. Thomas JR, Su WP,. Concurrence of lupus erythematosus and dermatitis herpetiformis. A report of nine cases. Arch Dermatol 1983; 119: 740-745.
47. Leonard WJ, Spolski R,. Interleukin-21: A modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 2005; 5: 688-698.
48. Park SW, Park SJ, Shin JI,. Another possible underlying mechanism for the positive association between celiac disease and systemic lupus erythematosus: The role of interleukin 21. J Rheumatol 2013; 40: 1619-1619.
49. Nakou M, Papadimitraki ED, Fanouriakis A, et al. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells. Clin Exp Rheumatol 2013; 31: 172-179.
50. Fina D, Sarra M, Caruso R, et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 2008; 57: 887-892.
51. Einarsdottir E, Koskinen LLE, de Kauwe AL, et al. Genome-wide analysis of extended pedigrees confirms IL2-IL21 linkage and shows additional regions of interest potentially influencing coeliac disease risk. Tissue Antigens 2011; 78: 428-437.
52. Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2007; 5: 1282-1290; quiz 1245.
53. Reifenstein EC, Reifenstein EC Jr., Reifenstein GH,. A variable symptom complex of undetermined etiology with fatal termination: Including conditions described as visceral erythema group (Osler), disseminated lupus erythematosus, atypical verrucous endocarditis (Libman-Sacks), fever of unknown origin (Christian) and diffuse peripheral vascular disease (Baehr and others). Arch Intern Med 1939; 63: 553-574.
54. Carone FA, Liebow AA,. Acute pancreatic lesions in patients treated with ACTH and adrenal corticoids. N Engl J Med 1957; 257: 690-697.
55. Cortese AF, Glenn F,. Hypocalcemia and tetany with steroid-induced acute pancreatitis. Arch Surg Chic Ill 1968; 96: 119-122.
56. Reynolds JC, Inman RD, Kimberly RP, Chuong JH, Kovacs JE, Walsh MB,. Acute pancreatitis in systemic lupus erythematosus: Report of twenty cases and a review of the literature. Medicine (Baltimore) 1982; 61: 25-32.
57. Netto AP, Dreiling DA,. Pancreatitis in disseminated lupus erythematosus: A case report. J Mt Sinai Hosp N Y 1960; 27: 291-295.
58. Pollak VE, Grove WJ, Kark RM, Muehrcke RC, Pirani CL, Steck IE,. Systemic lupus erythematosus simulating acute surgical condition of the abdomen. N Engl J Med 1958; 259: 258-266.
59. Sparberg M,. Recurrent acute pancreatitis associated with systemic lupus erythematosus. Report of a case. Am J Dig Dis 1967; 12: 522-526.
60. Ahmed QM, Arafat SM, Azad AK, et al. Gastrointestinal manifestations as initial presenting features in a 40 years old woman with systemic lupus erythematosus. Mymensingh Med J MMJ 2015; 24: 186-190.
61. Rodriguez EA, Sussman DA, Rodriguez VR,. Systemic lupus erythematosus pancreatitis: An uncommon presentation of a common disease. Am J Case Rep 2014; 15: 501-503.
62. Wang CH, Yao TC, Huang YL, Ou LS, Yeh KW, Huang JL,. Acute pancreatitis in pediatric and adult-onset systemic lupus erythematosus: A comparison and review of the literature. Lupus 2011; 20: 443-452.
63. Essaadouni L, Samar E, Krati K,. Pancreatitis as initial manifestation of systemic lupus erythematosus. Lupus 2010; 19: 884-887.
64. Makol A, Petri M,. Pancreatitis in systemic lupus erythematosus: Frequency and associated factors-a review of the Hopkins Lupus Cohort. J Rheumatol 2010; 37: 341-345.
65. Breuer GS, Baer A, Dahan D, Nesher G,. Lupus-associated pancreatitis. Autoimmun Rev 2006; 5: 314-318.
66. Dreiling DA, Robert J, Toledano AE,. Vascular pancreatitis. A clinical entity of growing importance. J Clin Gastroenterol 1988; 10: 3-6.
67. Serrano López MC, Yebra Bango M, López Bonet E, et al. Acute pancreatitis and systemic lupus erythematosus: Necropsy of a case and review of the pancreatic vascular lesions. Am J Gastroenterol 1991; 86: 764-767.
68. Seelig R, Seelig HP,. The possible role of serum complement system in the formal pathogenesis of acute pancreatitis II. Cobra venom factor pancreatitis-sodium taurocholate and deoxycholate pancreatitis. Acta Hepatogastroenterol (Stuttg) 1975; 22: 335-346.
69. Hamed I, Lindeman RD, Czerwinski AW,. Case report: Acute pancreatitis following corticosteroid and azathioprine therapy. Am J Med Sci 1978; 276: 211-219.
70. Pascual-Ramos V, Duarte-Rojo A, Villa AR, et al. Systemic lupus erythematosus as a cause and prognostic factor of acute pancreatitis. J Rheumatol 2004; 31: 707-712.
71. Nesher G, Breuer GS, Temprano K, et al. Lupus-associated pancreatitis. Semin Arthritis Rheum 2006; 35: 260-267.
72. van Hoek B,. The spectrum of liver disease in systemic lupus erythematosus. Neth J Med 1996; 48: 244-253.
73. Leggett BA,. The liver in systemic lupus erythematosus. J Gastroenterol Hepatol 1993; 8: 84-88.
74. Gibson T, Myers AR,. Subclinical liver disease in systemic lupus erythematosus. J Rheumatol 1981; 8: 752-759.
75. Miller MH, Urowitz MB, Gladman DD, Blendis LM,. The liver in systemic lupus erythematosus. Q J Med 1984; 53: 401-409.
76. Bessone F, Poles N, Roma MG,. Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World J Hepatol 2014; 6: 394-409.
77. Irving KS, Sen D, Tahir H, Pilkington C, Isenberg DA,. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus-a retrospective review of cases. Rheumatol Oxf Engl 2007; 46: 1171-1173.
78. Her M, Lee Y, Jung E, Kim T, Kim D,. Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis. Rheumatol Int 2011; 31: 79-84.
79. Vergani D, Mieli-Vergani G,. The impact of autoimmunity on hepatocytes. Semin Liver Dis 2007; 27: 140-151.
80. Gershwin ME, Mackay IR,. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology 2008; 47: 737-745.
81. Levy C, Lindor KD,. Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis. Clin Liver Dis 2003; 7: 901-910.
82. Cowling DC, Mackay IR, Taft LI,. Lupoid hepatitis. Lancet Lond Engl 1956; 271: 1323-1326.
83. Joske RA, King WE,. The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet Lond Engl 1955; 269: 477-480.
84. Runyon BA, LaBrecque DR, Anuras S,. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med 1980; 69: 187-194.
85. Mackay IR, Taft LI, Cowling DC,. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet Lond Engl 1959; 1: 65-69.
86. Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG,. Liver involvement in systemic lupus erythematosus: Case review of 40 patients. J Rheumatol 2008; 35: 2159-2164.
87. Efe C, Purnak T, Ozaslan E, et al. Autoimmune liver disease in patients with systemic lupus erythematosus: A retrospective analysis of 147 cases. Scand J Gastroenterol 2011; 46: 732-737.
88. Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
89. Lohse AW, Mieli-Vergani G,. Autoimmune hepatitis. J Hepatol 2011; 55: 171-182.
90. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of "autoimmune" hepatitis. Hepatology 1987; 7: 1333-1339.
91. Muratori P, Granito A, Pappas G, et al. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2009; 104: 1420-1425.
92. Efe C, Purnak T, Ozaslan E, Wahlin S,. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2010; 105: 226; author reply 226-227.
93. Zheng R-H, Wang J-H, Wang S-B, Chen J, Guan W-M, Chen M-H,. Clinical and immunopathological features of patients with lupus hepatitis. Chin Med J (Engl) 2013; 126: 260-266.
94. Carmona-Fernandes D, Santos MJ, Canhão H, Fonseca JE,. Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: Diagnostic performance and clinical profile. BMC Med 2013; 11: 98-98.
95. Arnett FC, Reichlin M,. Lupus hepatitis: An under-recognized disease feature associated with autoantibodies to ribosomal P. Am J Med 1995; 99: 465-472.
96. Kapila N, Higa JT, Longhi MS, Robson SC,. Autoimmune hepatitis: Clinical review with insights into the purinergic mechanism of disease. J Clin Transl Hepatol 2013; 1: 79-86.
97. Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER,. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982; 57: 365-370.
98. Shizuma T, Kuroda H,. A case of primary biliary cirrhosis which developed eight years after diagnosis of systemic lupus erythematosus. Intern Med Tokyo Jpn 2011; 50: 321-324.
99. González LA, Orrego M, Ramírez LA, Vásquez G,. Primary biliary cirrhosis/autoimmune hepatitis overlap syndrome developing in a patient with systemic lupus erythematosus: A case report and review of the literature. Lupus 2011; 20: 108-111.
100. Steffan W, Schulz CTD,. The gastrointestinal manifestations of systemic lupus erythematosus: A survey of the literature. Open Autoimmun J 2009; 1: 10-26.
101. Matsumoto T, Kobayashi S, Shimizu H, et al. The liver in collagen diseases: Pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 2000; 20: 366-373.
102. Takahashi A, Abe K, Saito R, et al. Liver dysfunction in patients with systemic lupus erythematosus. Intern Med Tokyo Jpn 2013; 52: 1461-1465.
103. Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 2015; 48: 192-197.
104. Shizuma T,. Clinical characteristics of concomitant systemic lupus erythematosus and primary biliary cirrhosis: A literature review. J Immunol Res 2015; 2015: e713728-e713728.
105. Agmon-Levin N, Shapira Y, Selmi C, et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010; 34: 55-58.
106. Miyazaki T, Ono M, Qu W-M, et al. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Eur J Immunol 2005; 35: 1510-1520.
107. Harada K, Ozaki S, Sudo Y, Tsuneyama K, Ohta H, Nakanuma Y,. Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis. Pathol Int 2003; 53: 8-17.
108. Han S, Guthridge JM, Harley ITW, et al. Osteopontin and systemic lupus erythematosus association: A probable gene-gender interaction. PloS One 2008; 3: e0001757-e0001757.
109. Huang D, Aghdassi E, Su J, et al. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. J Rheumatol 2012; 39: 254-261.